APA (7th ed.) Citation

EB, S., LL, L., RM, B., TR, G., S, P., ST, L., . . . JT, R. (2014). Rituximab therapy for refractory orbital inflammation: Results of a phase 1/2, dose-ranging, randomized clinical trial. JAMA ophthalmology, 132(5), 572. https://doi.org/10.1001/jamaophthalmol.2013.8179

Chicago Style (17th ed.) Citation

EB, Suhler, et al. "Rituximab Therapy for Refractory Orbital Inflammation: Results of a Phase 1/2, Dose-ranging, Randomized Clinical Trial." JAMA Ophthalmology 132, no. 5 (2014): 572. https://doi.org/10.1001/jamaophthalmol.2013.8179.

MLA (9th ed.) Citation

EB, Suhler, et al. "Rituximab Therapy for Refractory Orbital Inflammation: Results of a Phase 1/2, Dose-ranging, Randomized Clinical Trial." JAMA Ophthalmology, vol. 132, no. 5, 2014, p. 572, https://doi.org/10.1001/jamaophthalmol.2013.8179.